Physician

Adam Justin Waxman, MD

According to 2025 Medicare claims, Adam Waxman, MD (NPI: 1669766275) practices hematology/oncology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Montgomery, PA. This provider's primary affiliated billing organization is UNIVERSITY OF PENN-MEDICAL GROUP (NPI: 1679677975; TIN: 232743545) and primary practice location at 19104-5127.

Waxman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 353 traditional Medicare patients, billed 1,635 HCPCS/CPT codes, and received $107,098 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 635 prescription claims across 132 beneficiaries totaling $3,137,750 in drug costs, led by Revlimid (Lenalidomide). DME data shows 24 claims. Open Payments data shows 4 records totaling $184,836. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $25,772 to $107,098. Similarly, Part D prescription costs have moved sharply higher in recent years, from $18,599 to $3,137,750. In contrast, DME billing represents a smaller volume and declined steadily, from $1,699 to $1,122.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	74	291	$25,772
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	95	324	$31,800
2019	199	735	$68,447
2020	195	682	$61,996
2021	267	948	$94,400
2022	326	1,062	$98,207
2023	349	1,145	$106,402
2024	353	1,635	$107,098

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	55	126	$18,599
2016	35	57	$9,032
2017	20	40	$1,863
2018	45	155	$101,759
2019	66	445	$865,427
2020	76	390	$1,482,200
2021	89	502	$1,660,602
2022	111	552	$2,018,518
2023	132	502	$2,347,825
2024	132	635	$3,137,750

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	27	$1,490
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	22	$758
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	26	$1,047
2023	N/R	22	$949
2024	N/R	24	$1,065

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	48	48	$140
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	195	560	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	167	238	$71
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	33	38	$25
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	342	581	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	75	2,100	$1,295,642
Lenalidomide	Lenalidomide	76	2,128	$989,939
Pomalyst	Pomalidomide	23	630	$485,646
Brukinsa	Zanubrutinib	17	510	$169,268
Xarelto	Rivaroxaban	11	330	$6,112

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$881
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	12	$184

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	4	$184,836	Hospital Of The Univ Of Penna
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Justin Waxman, MD?

Tedicare shows public-source Medicare data for Adam Justin Waxman, MD (NPI 1669766275), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Justin Waxman, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Justin Waxman, MD?

Adam Justin Waxman, MD is linked to UNIVERSITY OF PENN-MEDICAL GROUP (billing NPI 1679677975) in the available physician profile data.

Does Adam Justin Waxman, MD have Open Payments data?

Adam Justin Waxman, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.